Analyze the financial impact of various gene testing methods (Whole Exome Sequencing vs Panel Gene Testing) using data visualization and statistical testings.
- contrast groups: Panel Testing vs EXOME SEQUENCE ANALYSIS
- target variables: charge (A), payment (B), denial rate (C), remit code (D), claims duration (E)
- covariates: financial class, DX, CCS categories
- unit of analysis: patient level (A-C) and account level (D, E)
- boxplots to show variability between and within case groups
- test pairwise difference between two groups (Pairwise Wilcoxon Rank Sum Test)
- test overall difference among multiple groups (Kruskal-Wallis Rank Sum Test)
Percentage of payment is overall significantly different among different financial classes based on Kruskal-Wallis Test.
